Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients

NCT07397481 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis
Arterial Hypertension

Interventions

DRUG: Nebivolol 5 mg
DRUG: Carvedilol 12.5 mg
DRUG: Nebivolol 2.5 mg
DRUG: Carvedilol 6.25 mg

Sponsor

Kafrelsheikh University